In the past few years, a number of medications have been introduced that lower the risk of cardiovascular disease in patients with diabetes. Previously, cardiovascular risk reduction was not correlated with A1c. Now there are new tools to reduce cardiovascular risk in those with diabetes. This lecture will review strategies to provide patients with diabetes with the greatest cardiovascular risk reduction.
1. Discuss the most recent medications that provide cardiovascular protection in patients with diabetes
2. Describe lifestyle changes to affect cardiovascular risk in patients with diabetes
3. Provide a recommendation on when and how to use medications to reduce the risk of cardiovascular disease in patients with diabetes
Disclosures: None Reported
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Grievance Policy: OPSC strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at 916-822-5246 or by email to firstname.lastname@example.org.
Kim Pfotenhauer, DO
Kim Pfotenhauer is a board certified osteopathic family physician and assistant professor at Touro University California College of Osteopathic Medicine in Vallejo, California.A graduate of Michigan State University, Dr. Pfotenhauer splits her time between clinical practice, academic teaching, and research in metabolic disease. She is currently completing a fellowship in diabetology at Touro University California and is board certified in advanced diabetes management.
Please wait ...